Article info
Original articles
Clinical science
Spectral-domain optical coherence tomography in subjects over 60 years of age, and its implications for designing clinical trials
- Correspondence to Dr Albert Caramoy, Department of Vitreo-Retinal Surgery, Center of Ophthalmology, University of Cologne, Kerpener Strasse 62, Cologne 50924, Germany; acaramoy{at}yahoo.co.uk
Citation
Spectral-domain optical coherence tomography in subjects over 60 years of age, and its implications for designing clinical trials
Publication history
- Accepted July 11, 2012
- First published August 3, 2012.
Online issue publication
September 22, 2012
Article Versions
- Previous version (3 August 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/3.0/ and http://creativecommons.org/licenses/by-nc/3.0/legalcode